$346 Million is the total value of Ghost Tree Capital, LLC's 63 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 129.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Buy | ISHARES TRput | $40,243,000 | +385.0% | 350,000 | +366.7% | 11.62% | +147.5% |
| XBI | Buy | SPDR SERIES TRUSTput | $21,632,000 | +96.0% | 400,000 | +81.8% | 6.25% | +0.0% |
| SPY | New | SPDR S&P 500 ETF TRput | $20,948,000 | – | 100,000 | +100.0% | 6.05% | – |
| GWPH | New | GW PHARMACEUTICALS PLCput | $11,904,000 | – | 130,000 | +100.0% | 3.44% | – |
| OPHT | Buy | OPHTHOTECH CORP | $10,971,000 | +116.3% | 215,000 | +79.2% | 3.17% | +10.4% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $10,508,000 | +88.7% | 90,000 | +125.0% | 3.03% | -3.7% |
| NUVA | Buy | NUVASIVE INC | $8,958,000 | +163.0% | 150,000 | +114.3% | 2.59% | +34.3% |
| MDT | Buy | MEDTRONIC PLC | $8,677,000 | +335.4% | 100,000 | +276.3% | 2.51% | +122.2% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $8,558,000 | +159.4% | 110,000 | +175.0% | 2.47% | +32.4% |
| EW | New | EDWARDS LIFESCIENCES CORP | $8,477,000 | – | 85,000 | +100.0% | 2.45% | – |
| CNMD | New | CONMED CORP | $8,353,000 | – | 175,000 | +100.0% | 2.41% | – |
| ACOR | New | ACORDA THERAPEUTICS INC | $8,289,000 | – | 325,000 | +100.0% | 2.39% | – |
| BSX | New | BOSTON SCIENTIFIC CORPcall | $8,180,000 | – | 350,000 | +100.0% | 2.36% | – |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $7,595,000 | -10.3% | 325,000 | -27.8% | 2.19% | -54.2% |
| AXGT | New | AXOVANT SCIENCES LTD | $7,383,000 | – | 575,000 | +100.0% | 2.13% | – |
| BLUE | New | BLUEBIRD BIO INC | $7,359,000 | – | 170,000 | +100.0% | 2.12% | – |
| BIIB | New | BIOGEN INC | $7,255,000 | – | 30,000 | +100.0% | 2.10% | – |
| SPNC | Buy | SPECTRANETICS CORP | $7,016,000 | +38.1% | 375,000 | +7.1% | 2.03% | -29.6% |
| CLVS | New | CLOVIS ONCOLOGY INCput | $6,860,000 | – | 500,000 | +100.0% | 1.98% | – |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $6,174,000 | +1639.2% | 450,000 | +2332.4% | 1.78% | +787.1% |
| NVRO | Buy | NEVRO CORP | $5,901,000 | +39.8% | 80,000 | +6.7% | 1.70% | -28.6% |
| SRPT | New | SAREPTA THERAPEUTICS INCput | $5,721,000 | – | 300,000 | +100.0% | 1.65% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $5,681,000 | – | 125,000 | +100.0% | 1.64% | – |
| LBIO | Buy | LION BIOTECHNOLOGIES INC | $5,670,000 | +346.5% | 700,000 | +180.0% | 1.64% | +127.7% |
| KTWO | New | K2M GROUP HLDGS INC | $5,432,000 | – | 350,000 | +100.0% | 1.57% | – |
| GHDX | New | GENOMIC HEALTH INC | $5,179,000 | – | 200,000 | +100.0% | 1.50% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS INcall | $4,994,000 | – | 35,000 | +100.0% | 1.44% | – |
| ELGX | New | ENDOLOGIX INC | $4,984,000 | – | 400,000 | +100.0% | 1.44% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS | $4,828,000 | – | 1,700,000 | +100.0% | 1.39% | – |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $4,658,000 | – | 120,000 | +100.0% | 1.34% | – |
| SAGE | New | SAGE THERAPEUTICS INCcall | $4,520,000 | – | 150,000 | +100.0% | 1.30% | – |
| WMGI | Buy | WRIGHT MED GROUP N V | $4,343,000 | +109.3% | 250,000 | +100.0% | 1.25% | +6.8% |
| TSRO | New | TESARO INC | $4,203,000 | – | 50,000 | +100.0% | 1.21% | – |
| TSRO | New | TESARO INCcall | $4,203,000 | – | 50,000 | +100.0% | 1.21% | – |
| HZNP | Sell | HORIZON PHARMA PLC | $4,118,000 | -41.5% | 250,000 | -41.2% | 1.19% | -70.2% |
| PCRX | New | PACIRA PHARMACEUTICALS INC | $4,048,000 | – | 120,000 | +100.0% | 1.17% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $3,814,000 | – | 200,000 | +100.0% | 1.10% | – |
| FLML | New | FLAMEL TECHNOLOGIES SAsponsored adr | $3,759,000 | – | 350,000 | +100.0% | 1.09% | – |
| HZNP | New | HORIZON PHARMA PLCcall | $3,294,000 | – | 200,000 | +100.0% | 0.95% | – |
| RPTP | New | RAPTOR PHARMACEUTICAL CORP | $3,222,000 | – | 600,000 | +100.0% | 0.93% | – |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $3,150,000 | -8.0% | 250,000 | +11.1% | 0.91% | -53.0% |
| CELG | Sell | CELGENE CORP | $2,466,000 | -72.7% | 25,000 | -72.3% | 0.71% | -86.1% |
| IMMU | New | IMMUNOMEDICS INC | $2,320,000 | – | 1,000,000 | +100.0% | 0.67% | – |
| ENTL | Buy | ENTELLUS MED INC | $2,192,000 | +9.5% | 120,000 | +9.1% | 0.63% | -44.1% |
| SRPT | New | SAREPTA THERAPEUTICS INCcall | $1,907,000 | – | 100,000 | +100.0% | 0.55% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $1,812,000 | – | 12,700 | +100.0% | 0.52% | – |
| RIGL | New | RIGEL PHARMACEUTICALS INC | $1,784,000 | – | 800,000 | +100.0% | 0.52% | – |
| VCYT | VERACYTE INC | $1,719,000 | -6.8% | 341,708 | 0.0% | 0.50% | -52.5% | |
| FLDM | New | FLUIDIGM CORP DEL | $1,355,000 | – | 150,000 | +100.0% | 0.39% | – |
| ADHD | ALCOBRA LTD | $1,347,000 | +18.5% | 300,000 | 0.0% | 0.39% | -39.5% | |
| ASND | New | ASCENDIS PHARMA A Ssponsored adr | $1,327,000 | – | 100,000 | +100.0% | 0.38% | – |
| GILD | New | GILEAD SCIENCES INC | $1,251,000 | – | 15,000 | +100.0% | 0.36% | – |
| TNDM | TANDEM DIABETES CARE INC | $1,131,000 | -13.5% | 150,000 | 0.0% | 0.33% | -55.8% | |
| CRBP | New | CORBUS PHARMACEUTICALS HLDGS | $897,000 | – | 300,000 | +100.0% | 0.26% | – |
| RDUS | New | RADIUS HEALTH INC | $735,000 | – | 20,000 | +100.0% | 0.21% | – |
| MDVN | New | MEDIVATION INC | $633,000 | – | 10,500 | +100.0% | 0.18% | – |
| AKTX | AKARI THERAPEUTICS PLCsponsored adr | $629,000 | -3.7% | 46,622 | 0.0% | 0.18% | -50.8% | |
| IMMU | New | IMMUNOMEDICS INCcall | $464,000 | – | 200,000 | +100.0% | 0.13% | – |
| HRTX | HERON THERAPEUTICS INC | $451,000 | -5.1% | 25,000 | 0.0% | 0.13% | -51.7% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $410,000 | -92.3% | 75,000 | -70.0% | 0.12% | -96.1% |
| AGLE | New | AEGLEA BIOTHERAPEUTICS INC | $243,000 | – | 50,000 | +100.0% | 0.07% | – |
| SGYPQ | New | SYNERGY PHARMACEUTICALS DEL | $84,000 | – | 22,000 | +100.0% | 0.02% | – |
| OCRX | Sell | OCERA THERAPEUTICS INC | $68,000 | -48.5% | 35,801 | -20.4% | 0.02% | -73.3% |
| SBBP | Exit | STRONGBRIDGE BIOPHARMA PLC | $0 | – | -72,726 | -100.0% | -0.19% | – |
| ADAP | Exit | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $0 | – | -50,000 | -100.0% | -0.23% | – |
| VTAE | Exit | VITAE PHARMACEUTICALS INC | $0 | – | -101,188 | -100.0% | -0.38% | – |
| ENDP | Exit | ENDO INTL PLC | $0 | – | -24,100 | -100.0% | -0.38% | – |
| CHMA | Exit | CHIASMA INC | $0 | – | -75,000 | -100.0% | -0.39% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -40,000 | -100.0% | -0.46% | – |
| IHE | Exit | ISHARES TRu.s. pharma etf | $0 | – | -9,800 | -100.0% | -0.76% | – |
| GNMK | Exit | GENMARK DIAGNOSTICS INC | $0 | – | -300,000 | -100.0% | -0.90% | – |
| CYNA | Exit | CYNAPSUS THERAPEUTICS INC | $0 | – | -151,535 | -100.0% | -1.02% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -250,000 | -100.0% | -1.09% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -25,253 | -100.0% | -1.14% | – |
| STJ | Exit | ST JUDE MED INC | $0 | – | -36,500 | -100.0% | -1.14% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -1.15% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -75,000 | -100.0% | -1.19% | – |
| DBVT | Exit | DBV TECHNOLOGIES S Asponsored adr | $0 | – | -45,000 | -100.0% | -1.46% | – |
| VRX | Exit | VALEANT PHARMACEUTICALS INTLcall | $0 | – | -100,000 | -100.0% | -1.49% | – |
| RMD | Exit | RESMED INC | $0 | – | -50,000 | -100.0% | -1.64% | – |
| IHI | Exit | ISHARES TRu.s. med dvc etf | $0 | – | -25,000 | -100.0% | -1.73% | – |
| IART | Exit | INTEGRA LIFESCIENCES HLDGS C | $0 | – | -50,000 | -100.0% | -1.91% | – |
| IHF | Exit | ISHARES TRus hlthcr pr etf | $0 | – | -39,500 | -100.0% | -2.73% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -160,000 | -100.0% | -2.90% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDcall | $0 | – | -100,000 | -100.0% | -3.03% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -140,000 | -100.0% | -3.22% | – |
| ABBV | Exit | ABBVIE INCcall | $0 | – | -100,000 | -100.0% | -3.23% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -700,000 | -100.0% | -3.37% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORPcall | $0 | – | -100,000 | -100.0% | -4.99% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCput | $0 | – | -350,000 | -100.0% | -5.54% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.